Back to Search
Start Over
Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2012 Apr; Vol. 53 (4), pp. 718-20. Date of Electronic Publication: 2011 Dec 05. - Publication Year :
- 2012
- Subjects :
- Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized administration & dosage
Antibodies, Monoclonal, Humanized adverse effects
Bevacizumab
Clinical Trials as Topic
Cyclophosphamide administration & dosage
Cyclophosphamide adverse effects
Doxorubicin administration & dosage
Doxorubicin adverse effects
Female
Humans
Male
Middle Aged
Prednisolone administration & dosage
Prednisolone adverse effects
Vincristine administration & dosage
Vincristine adverse effects
Antineoplastic Combined Chemotherapy Protocols adverse effects
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Heart Diseases chemically induced
Lymphoma, T-Cell, Peripheral drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1029-2403
- Volume :
- 53
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Report
- Accession number :
- 21916830
- Full Text :
- https://doi.org/10.3109/10428194.2011.623256